References
- Chao CY, Sung PJ, Wang WH, Kuo YH. 2014. Anti-inflammatory effect of Momordica charantia in sepsis mice. Molecules. 19(8):12777–12788.
- Chen F, Huang G, Huang H. 2021. Preparation, analysis, antioxidant activities in vivo of phosphorylated polysaccharide from Momordica charantia. Carbohydr Polym. 252:117179.
- Chen F, Huang G, Yang Z, Hou Y. 2019. Antioxidant activity of Momordica charantia polysaccharide and its derivatives. Int J Biol Macromol. 138:673–680.
- Cortez-Navarrete M, Martínez-Abundis E, Pérez-Rubio KG, González-Ortiz M, Méndez-Del Villar M. 2018. Momordica charantia administration improves insulin secretion in type 2 diabetes mellitus. J Med Food. 21(7):672–677.
- Fang EF, Ng TB. 2011. Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties. Curr Mol Med. 11(5):417–436.
- Han C, Hui Q, Wang Y. 2008. Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems. Nat Prod Res. 22(13):1112–1119.
- Hasegawa S, Miura T, Hirose Y, Iitaka Y. 1985. A new rearranged lanostanoid, mariesiic acid A, from the seed of Abies mariesii. Chem Lett. 14(10):1589–1592.
- Jia S, Shen M, Zhang F, Xie J. 2017. Recent advances in Momordica charantia: functional components and biological activities. IJMS. 18(12):2555.
- Kulkarni P, Lohidasan S, Mahadik K. 2021. Isolation, characterisation and investigation of in vitro antidiabetic and antioxidant activity of phytoconstituents from fruit of Momordica charantia Linn. Nat Prod Res. 35(6):1035–1037.
- Li YC, Xu XJ, Yang J, Wu XG, Fu QY. 2016. One new 19-nor cucurbitane-type triterpenoid from the stems of Momordica charantia. Nat Prod Res. 30(8):973–978.
- Liu Y, Wang YM, Wu WM, Song J, Ruan HL. 2017. Triterpenoids and lignans from the fruit of Schisandra sphenanthera. Fitoterapia. 116:10–16.
- Mishra S, Ankit Sharma R, Gogna N, Dorai K. 2022. NMR-based metabolomic profiling of the differential concentration of phytomedicinal compounds in pericarp, skin and seeds of Momordica charantia (bitter melon). Nat Prod Res. 36(1):390–395.
- Peter EL, Kasali FM, Deyno S, Mtewa A, Nagendrappa PB, Tolo CU, Ogwang PE, Sesaazi D. 2019. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis. J Ethnopharmacol. 231:311–324.
- Sun Y, Sun F, Li J, Wu M, Fan X, Meng Y, Meng Y. 2016. Mono-PEGylation of alpha-MMC and MAP30 from Momordica charantia L.: Production, identification and anti-tumor activity. Molecules. 21(11):1457.
- Yaldız G, Sekeroglu N, Kulak M, Demirkol G. 2015. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: A case study for adaptation. Nat Prod Res. 29(6):543–545.
- Yang XW, Li SM, Wu L, Li YL, Feng L, Shen YH, Tian JM, Tang J, Wang N, Liu YH, et al. 2010. Abiesatrines A-J: Anti-inflammatory and antitumor triterpenoids from Abies georgei Orr. Org Biomol Chem. 8(11):2609–2616.
- Yu HY, Li J, Liu Y, Wu WM, Ruan HL. 2016. Triterpenoids from the fruit of Schisandra glaucescens. Fitoterapia. 113:64–68.
- Zhou SY, Wang WG, Li HM, Zhang RB, Li HZ, Li RT. 2009. Schisanlactone H and sphenanthin A, new metabolites from Schisandra sphenanthera. J Asian Nat Prod Res. 11(10):861–866.